BRÈVE

sur CROSSJECT (EPA:ALCJ)

Crossject: Information relating to the total number of voting rights and shares making up the share capital

Graphique de l'évolution du cours de l'action CROSSJECT (EPA:ALCJ).

Crossject (ISIN: FR0011716265; Ticker: ALCJ), a specialized pharmacy company, has released information on the number of voting rights and shares in its share capital as of May 31, 2024. In accordance with articles 223-16 of the General Regulations of the AMF and L.233-8 II of the Commercial Code, the company has detailed this information.

As of June 6, 2024, the share capital of Crossject consisted of 41,088,344 shares. The total number of theoretical voting rights was 49,339,434 and the number of exercisable voting rights amounted to 49,208,662. It should be noted that 130,772 shares were deprived of voting rights, including the shares held by the society itself.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de CROSSJECT